Evidence map›Paper›PMID 40276113›Full record

SynthesisFrontiers in human neuroscience2025

Artificial intelligence in ADHD: a global perspective on research hotspots, trends and clinical applications.

Xiaofang Wang, Qianfang Jia, Lvyuan Liang, Weiwei Zhou, Weihua Yang, Jingfeng Mu

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in human neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiaofang Wang *Hebei University of Chinese Medicine, Shijiazhuang, China.
Qianfang Jia *Department of Children's Rehabilitation, First Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Lvyuan LiangSchool of Pediatric Medicine, Henan University of Chinese Medicine, Zhengzhou, China.
Weiwei ZhouShenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, China.
Weihua YangShenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, China.
Jingfeng MuShenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Artificial Intelligence (AI), has garnered attention in research on attention deficit hyperactivity disorder (ADHD). In the future, AI may have clinical applications in ADHD, particularly in facilitating the objective diagnosis and classification of ADHD. This study aimed to comprehensively analyze the current status and research frontiers of AI applications in ADHD, identifying hotspots and trends to guide future research directions and promote clinical advancements in this field. Methods: Articles in the field of AI applications in ADHD were from the Web of Science Core Collection (WoSCC) database. Analysis was conducted using CiteSpace 6.3.R.1. Additionally, high-impact articles were analyzed. Results: A total of 342 articles from 50 countries and regions were included. The United States led with 103 articles, having the highest H-index of 21, followed by China with 69 articles, and England with 34 articles. The State University of New York System produced the most articles (11), and Conclusion: AI technologies have become a prominent topic in ADHD research, with the United States, China, and England leading in articles and influence. The State University of New York System was the most influential institution, while

Indexed as

artificial intelligenceattention deficit hyperactivity disorderdiagnosishotspottrend

Identifiers

PMID40276113
PMCPMC12018397

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.